The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof. Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders.
申请公布号
WO2014113942(A1)
申请公布日期
2014.07.31
申请号
WO2013CN70898
申请日期
2013.01.23
申请人
MERCK SHARP & DOHME CORP.;WU, HAO
发明人
WU, HAO;KIM, RONALD M.;LIU, JIAN;LIU, SHILAN;YANG, CHUNDAO;ZHENG, SHULING